Clinical trial

RCT of Progesterone to Prevent Preterm Birth in Nulliparous Women With a Short…

NCT00439374 · The George Washington University Biostatistics Center, Other · Terminated

Key facts

NCT number NCT00439374
Title RCT of Progesterone to Prevent Preterm Birth in Nulliparous Women With a Short Cervix
Official title A Randomized Trial of 17 Alpha-Hydroxyprogesterone Caproate for Prevention of Preterm Birth in Nulliparous Women With a Short Cervix
Acronym SCAN
Lead sponsor The George Washington University Biostatistics Center, Other
Collaborators Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH
Status Terminated
Phase Phase 3
Study type Interventional
Conditions Preterm Delivery, Cervical Length
Intervention type Drug, Other
Interventions 17 alpha-hydroxyprogesterone caproate, Placebo Oil
Enrollment 657
Start date Apr 1, 2007
Primary completion May 1, 2011
Completion Dec 1, 2011
First posted Feb 23, 2007
Last update posted Jul 15, 2019
Countries United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies